Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin chemotherapy and involved node radiotherapy in stage IIA/B seminoma
2011-005840-87Phase 2Terminated
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Jul 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of carboplatin in Seminomatous germ cell testicular cancer, sponsored by Swiss Group for Clinical Cancer Research. Primary endpoint: Progression-free survival at 3 years. Started Jul 2013; status: terminated.
02
Drugs
carboplatin
03
Conditions
Seminomatous germ cell testicular cancer
Beyond the preview
Go deeper on 2011-005840-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005840-87.